SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 27 filers reported holding SILENCE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $523,376 | +45.0% | 53,297 | -18.8% | 0.00% | – |
| Q2 2023 | $360,834 | -19.9% | 65,606 | -9.7% | 0.00% | – |
| Q1 2023 | $450,597 | -86.0% | 72,677 | -65.6% | 0.00% | – |
| Q4 2022 | $3,217,339 | +106.6% | 210,973 | +36.0% | 0.00% | – |
| Q3 2022 | $1,557,000 | -14.3% | 155,159 | +1.2% | 0.00% | – |
| Q2 2022 | $1,817,000 | -37.0% | 153,293 | +1.1% | 0.00% | – |
| Q1 2022 | $2,882,000 | -27.7% | 151,666 | -9.1% | 0.00% | – |
| Q4 2021 | $3,986,000 | +1728.4% | 166,854 | +1471.9% | 0.00% | – |
| Q3 2021 | $218,000 | -12.8% | 10,615 | +11.0% | 0.00% | – |
| Q2 2021 | $250,000 | +7.3% | 9,565 | -5.5% | 0.00% | – |
| Q1 2021 | $233,000 | +429.5% | 10,118 | +405.9% | 0.00% | – |
| Q4 2020 | $44,000 | +37.5% | 2,000 | 0.0% | 0.00% | – |
| Q3 2020 | $32,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,312,233 | $8,135,845 | 3.37% |
| TCG Crossover Management, LLC | 2,104,875 | $13,050,225 | 2.54% |
| M28 Capital Management LP | 145,900 | $904,580 | 1.02% |
| Lombard Odier Asset Management (Europe) Ltd | 3,293,405 | $20,419,111 | 1.01% |
| Deep Track Capital, LP | 1,951,580 | $12,099,796 | 0.50% |
| Lombard Odier Asset Management (USA) Corp | 3,959,101 | $20,689,170 | 0.46% |
| Frazier Life Sciences Management, L.P. | 881,173 | $5,463,273 | 0.40% |
| BVF INC/IL | 1,508,416 | $9,352,179 | 0.34% |
| Parkman Healthcare Partners LLC | 158,774 | $984,399 | 0.21% |
| Artal Group S.A. | 505,074 | $3,131 | 0.19% |